Is GASTRIC CANCER STAGE IV a side effect of PREDNISONE TAB ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of PREDNISONE TAB patients who developed GASTRIC CANCER STAGE IV.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 3 individuals taking PREDNISONE TAB reported GASTRIC CANCER STAGE IV to the FDA. A total of 37145 PREDNISONE TAB drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between PREDNISONE TAB and GASTRIC CANCER STAGE IV. In doing so, we compare PREDNISONE TAB with other drugs that cause GASTRIC CANCER STAGE IV, to help you evaluate whether or not PREDNISONE TAB causes GASTRIC CANCER STAGE IV. Likewise, this page shows the most highly-reported side effects of PREDNISONE TAB, so you can see if GASTRIC CANCER STAGE IV ranks among PREDNISONE TAB's most well-known side effects.

Summary Statistics
Reports of PREDNISONE TAB causing GASTRIC CANCER STAGE IV: 3
Reports of any side effect of PREDNISONE TAB : 37145
Percentage of PREDNISONE TAB patients where GASTRIC CANCER STAGE IV is a reported side effect: 0.0081%

FDA reports of any drug causing GASTRIC CANCER STAGE IV : 65
Average percentage for all medicated patients where GASTRIC CANCER STAGE IV is reported as a complication: 0.0004%

Physician opinion on PREDNISONE TAB as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing PREDNISONE TAB:

RHEUMATOID ARTHRITIS ( 2379 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1844 patients )
DRUG USE FOR UNKNOWN INDICATION ( 1728 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 954 patients )
CROHN'S DISEASE ( 843 patients )
MULTIPLE MYELOMA ( 630 patients )
RENAL TRANSPLANT ( 507 patients )
PROSTATE CANCER ( 318 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 314 patients )
NON-HODGKIN'S LYMPHOMA ( 285 patients )
B-CELL LYMPHOMA ( 263 patients )
IMMUNOSUPPRESSION ( 250 patients )
ASTHMA ( 241 patients )
PROSTATE CANCER METASTATIC ( 219 patients )
COLITIS ULCERATIVE ( 210 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 189 patients )
ARTHRITIS ( 182 patients )
INFLAMMATION ( 156 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 154 patients )
LIVER TRANSPLANT ( 149 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 138 patients )
PREMEDICATION ( 135 patients )
HODGKIN'S DISEASE ( 129 patients )
LYMPHOMA ( 128 patients )
PSORIATIC ARTHROPATHY ( 115 patients )
PAIN ( 90 patients )
ANKYLOSING SPONDYLITIS ( 81 patients )
MANTLE CELL LYMPHOMA ( 73 patients )
ILL-DEFINED DISORDER ( 72 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 72 patients )
T-CELL LYMPHOMA ( 71 patients )
JUVENILE ARTHRITIS ( 69 patients )
SARCOIDOSIS ( 65 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA ( 64 patients )
POLYMYALGIA RHEUMATICA ( 60 patients )
BRONCHITIS ( 55 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 54 patients )
LUNG TRANSPLANT ( 54 patients )
TEMPORAL ARTERITIS ( 51 patients )
HEART TRANSPLANT ( 49 patients )
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED ( 45 patients )
GRAFT VERSUS HOST DISEASE ( 43 patients )
SEVERE ACUTE RESPIRATORY SYNDROME ( 43 patients )
BURKITT'S LYMPHOMA ( 43 patients )
PNEUMONIA ( 42 patients )
DYSPNOEA ( 41 patients )
ARTHRALGIA ( 37 patients )
MALIGNANT LYMPHOID NEOPLASM ( 35 patients )
SINUSITIS ( 35 patients )
PSORIASIS ( 33 patients )
RASH ( 32 patients )
HYPERSENSITIVITY ( 31 patients )
URTICARIA ( 30 patients )
WEGENER'S GRANULOMATOSIS ( 30 patients )
PROPHYLAXIS ( 30 patients )
B PRECURSOR TYPE ACUTE LEUKAEMIA ( 29 patients )
POLYARTHRITIS ( 28 patients )
TRANSPLANT REJECTION ( 27 patients )
DERMATOMYOSITIS ( 27 patients )
MYASTHENIA GRAVIS ( 27 patients )
UVEITIS ( 26 patients )
KIDNEY TRANSPLANT REJECTION ( 26 patients )
PEMPHIGUS ( 25 patients )
NEPHROTIC SYNDROME ( 25 patients )
AUTOIMMUNE HEPATITIS ( 25 patients )
STEROID THERAPY ( 25 patients )
PULMONARY FIBROSIS ( 24 patients )
COLITIS ( 24 patients )
RESPIRATORY DISORDER ( 24 patients )
LUNG DISORDER ( 23 patients )
AUTOIMMUNE DISORDER ( 23 patients )
MULTIPLE SCLEROSIS ( 23 patients )
GOUT ( 23 patients )
ADRENAL INSUFFICIENCY ( 22 patients )
DERMATITIS CONTACT ( 21 patients )
MYALGIA ( 19 patients )
IDIOPATHIC PULMONARY FIBROSIS ( 19 patients )
LUPUS NEPHRITIS ( 19 patients )
MUSCULOSKELETAL PAIN ( 19 patients )
ANTIINFLAMMATORY THERAPY ( 18 patients )
INFLAMMATORY BOWEL DISEASE ( 18 patients )
CHEMOTHERAPY ( 18 patients )
PRURITUS ( 18 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 17 patients )
BEHCET'S SYNDROME ( 17 patients )
TRANSPLANT ( 17 patients )
COUGH ( 16 patients )
EMPHYSEMA ( 16 patients )
INTERSTITIAL LUNG DISEASE ( 16 patients )
DRUG EXPOSURE DURING PREGNANCY ( 16 patients )
OSTEOARTHRITIS ( 15 patients )
SWELLING ( 15 patients )
VASCULITIS ( 14 patients )
HERPES ZOSTER ( 14 patients )
FIBROMYALGIA ( 14 patients )
ACNE ( 14 patients )
MYELOFIBROSIS ( 13 patients )
ANAEMIA HAEMOLYTIC AUTOIMMUNE ( 11 patients )
CONNECTIVE TISSUE DISORDER ( 11 patients )
UPPER RESPIRATORY TRACT INFECTION ( 11 patients )
POLYMYOSITIS ( 11 patients )
PAIN IN EXTREMITY ( 11 patients )
LUNG INFECTION ( 11 patients )
ADDISON'S DISEASE ( 10 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 10 patients )
RENAL DISORDER ( 10 patients )
DRUG HYPERSENSITIVITY ( 10 patients )
BACK PAIN ( 10 patients )
CRYPTOGENIC ORGANISING PNEUMONIA ( 10 patients )
RENAL AND PANCREAS TRANSPLANT ( 9 patients )
CHRONIC GRAFT VERSUS HOST DISEASE ( 9 patients )
LIVER DISORDER ( 9 patients )
CONDITION AGGRAVATED ( 9 patients )
SJOGREN'S SYNDROME ( 9 patients )
PLATELET COUNT DECREASED ( 9 patients )
POLYCHONDRITIS ( 9 patients )
JOINT SWELLING ( 9 patients )
THROMBOCYTOPENIA ( 8 patients )
ECZEMA ( 8 patients )
MULTIPLE SCLEROSIS RELAPSE ( 8 patients )
VESTIBULAR DISORDER ( 8 patients )
ENDOCRINE OPHTHALMOPATHY ( 8 patients )
ALLERGIC GRANULOMATOUS ANGIITIS ( 8 patients )
LEUKOCYTOCLASTIC VASCULITIS ( 8 patients )
OEDEMA PERIPHERAL ( 8 patients )
IRITIS ( 8 patients )
LOWER RESPIRATORY TRACT INFLAMMATION ( 8 patients )
OSTEOPOROSIS ( 7 patients )
ABDOMINAL PAIN ( 7 patients )
PLEURISY ( 7 patients )
ARTERITIS ( 7 patients )
GLOMERULONEPHRITIS ( 7 patients )
ANAEMIA ( 7 patients )
AUTOIMMUNE THROMBOCYTOPENIA ( 7 patients )
LYMPHOMA AIDS RELATED ( 7 patients )
CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION ( 7 patients )
INFECTION ( 7 patients )
SCLERODERMA ( 7 patients )
B-CELL TYPE ACUTE LEUKAEMIA ( 6 patients )
PALLIATIVE CARE ( 6 patients )
PYODERMA GANGRENOSUM ( 6 patients )
HAEMOLYTIC ANAEMIA ( 6 patients )
DIARRHOEA ( 6 patients )
NAUSEA ( 6 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE III ( 6 patients )
MYELODYSPLASTIC SYNDROME ( 6 patients )
PEMPHIGOID ( 6 patients )
NEOPLASM MALIGNANT ( 6 patients )
CASTLEMAN'S DISEASE ( 6 patients )
PRIMARY EFFUSION LYMPHOMA ( 6 patients )
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS ( 6 patients )
RESPIRATORY TRACT INFECTION ( 6 patients )
WALDENSTROM'S MACROGLOBULINAEMIA ( 5 patients )
ACUTE MYELOID LEUKAEMIA ( 5 patients )
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV ( 5 patients )
BURKITT'S LEUKAEMIA ( 5 patients )
NON-HODGKIN'S LYMPHOMA STAGE III ( 5 patients )
APLASIA PURE RED CELL ( 5 patients )
ANAPHYLACTIC REACTION ( 5 patients )
STEM CELL TRANSPLANT ( 5 patients )
FATIGUE ( 5 patients )
ADVERSE DRUG REACTION ( 5 patients )
DRUG THERAPY ( 5 patients )
DERMATITIS ( 5 patients )
HODGKIN'S DISEASE STAGE II ( 5 patients )
LUNG TRANSPLANT REJECTION ( 5 patients )
PLASMACYTOMA ( 5 patients )
FACIAL PALSY ( 5 patients )
IMMUNE RECONSTITUTION SYNDROME ( 5 patients )
MASTOCYTOSIS ( 5 patients )
PNEUMOCYSTIS JIROVECI PNEUMONIA ( 5 patients )
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ( 5 patients )
CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME ( 5 patients )
ARTHROPOD BITE ( 5 patients )
B-CELL LYMPHOMA STAGE IV ( 5 patients )
AMYLOIDOSIS ( 4 patients )
THROMBOTIC MICROANGIOPATHY ( 4 patients )
SPONDYLOARTHROPATHY ( 4 patients )
GASTROINTESTINAL DISORDER ( 4 patients )
LEUKAEMIA ( 4 patients )
PERICARDITIS ( 4 patients )
BACTERIAL INFECTION ( 4 patients )
ADRENAL DISORDER ( 4 patients )
HYPEREOSINOPHILIC SYNDROME ( 4 patients )
ANGIOEDEMA ( 4 patients )
ABORTION SPONTANEOUS ( 4 patients )
ARTHROPATHY ( 4 patients )
BLINDNESS ( 4 patients )
TENDONITIS ( 4 patients )
DEMYELINATING POLYNEUROPATHY ( 4 patients )
EYE DISORDER ( 4 patients )
POLYCYTHAEMIA VERA ( 4 patients )
DUCHENNE MUSCULAR DYSTROPHY ( 4 patients )
EYE INFLAMMATION ( 4 patients )
ALVEOLITIS ALLERGIC ( 4 patients )
THROMBOCYTOPENIC PURPURA ( 4 patients )
PULMONARY HYPERTENSION ( 4 patients )
PERICARDIAL EFFUSION ( 4 patients )
SYSTEMIC SCLEROSIS ( 4 patients )
NEPHROPATHY ( 4 patients )
MYELOMA RECURRENCE ( 4 patients )
NON-HODGKIN'S LYMPHOMA STAGE IV ( 4 patients )
MYELOPROLIFERATIVE DISORDER ( 4 patients )
PANCREATITIS ( 4 patients )
POLYARTERITIS NODOSA ( 4 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 4 patients )
SCIATICA ( 4 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 4 patients )
ASTHENIA ( 3 patients )
BRONCHOSPASM ( 3 patients )

Drugs with high FDA adverse event association with GASTRIC CANCER STAGE IV:

METHOTREXATE (10 patients)
FOLIC ACID (9 patients)
PREDNISOLONE (8 patients)
REMICADE (8 patients)
RHEUMATREX (7 patients)
ENBREL (5 patients)
LANSOPRAZOLE (5 patients)
MUCOSTA (5 patients)
ABATACEPT (4 patients)
ACTEMRA (4 patients)
ACTONEL (4 patients)
ADONA (4 patients)
ALENDRONIC ACID (4 patients)
ASPIRIN (4 patients)
CISPLATIN (4 patients)
CLOPIDOGREL BISULFATE (4 patients)
CREON (4 patients)
DOXAZOSIN MESYLATE (4 patients)
FLUOROURACIL (4 patients)
GLEEVEC (4 patients)
LANTUS (4 patients)
LEUPROLIDE ACETATE (4 patients)
NABILONE (4 patients)
PLAVIX (4 patients)
REVLIMID (4 patients)
AZULFIDINE (3 patients)
CALCIUM CARBONATE (3 patients)
CODEINE PHOSPHATE AND ACETAMINOPHEN (3 patients)
CYCLOPHOSPHAMIDE (3 patients)
ERGOCALCIFEROL (3 patients)
FERROUS SULFATE (3 patients)
INDAPAMIDE (3 patients)
ISONIAZID (3 patients)
KALYDECO (3 patients)
METHYLPREDNISOLONE (3 patients)
METOPROLOL (3 patients)
OMEPRAZOLE (3 patients)
PERINDOPRIL (3 patients)
PREDNISONE (3 patients)
PREDNISONE TAB (3 patients)
PREDONINE (3 patients)
ALBUTEROL (2 patients)
ALFAROL (2 patients)
AMIODARONE (2 patients)
CAPECITABINE (2 patients)
CERTOLIZUMAB PEGOL (2 patients)
CERTOLIZUMAB PEGOL (CERTOLIZUMAB PEGOL) (2 patients)
CITRIC ACID AND SODIUM CITRATE AND SODIUM PHOSPHATE MONOBASIC (ANHYDRA (2 patients)
CLOPIDOGREL (2 patients)
CRESTOR (2 patients)
DEXAMETHASONE (2 patients)
DILTIAZEM (2 patients)
DOCUSATE SODIUM (2 patients)
ENOXAPARIN SODIUM (2 patients)
EPIRUBICIN HCL (2 patients)
FAMOTIDINE (2 patients)
FINASTERIDE (2 patients)
FOLINIC ACID (2 patients)
FORTEO (2 patients)
HEPARIN (2 patients)
HUMIRA (2 patients)
HYDROMORPH CONTIN CR (2 patients)
HYDROMORPHONE HCL (2 patients)
HYPEN (2 patients)
IMIDAPRIL HYDROCHLORIDE (2 patients)
IRINOTECAN HCL (2 patients)
ITAVASTATIN (2 patients)
LOXONIN (2 patients)
MELOXICAM (2 patients)
METOPROLOL TARTRATE (2 patients)
NEXIUM (2 patients)
NORVASC (2 patients)
PANTOPRAZOLE SODIUM (2 patients)
PRAVASTATIN (2 patients)
PREGABALIN (2 patients)
PROTONIX (2 patients)
PYRIDOXINE HCL (2 patients)
RAMIPRIL (2 patients)
RETEPLASE (RETEPLASE) (2 patients)
SELBEX (2 patients)
SENECOT (2 patients)
SIMVASTATIN (2 patients)
TS-1 (2 patients)
ZEPOLAS (2 patients)
ABCIXIMAB (ABCIXIMAB) (1 patients)
ACTISKENAN (1 patients)
AGGRENOX (1 patients)
ALL OTHER THERAPEUTIC PRODUCTS (1 patients)
ANALGESICS (1 patients)
ANTI NAUSEA PILL (1 patients)
ANTIEMETICS AND ANTINAUSEANTS (1 patients)
ANTIHYPERTENSIVES (1 patients)
ASCAL (1 patients)
ATARAX (1 patients)
ATENOLOL (1 patients)
AVONEX (1 patients)
BICALUTAMIDE (1 patients)
CALCICHEW D (1 patients)
CARDIZEM (1 patients)
CELLCEPT (1 patients)
CEMIDON B6 (1 patients)
CEREZYME (1 patients)
CETUXIMAB (1 patients)
CLARITH (1 patients)
CLARITHROMYCIN (1 patients)
CO-APROVEL (1 patients)
CO-CODAMOL (1 patients)
COUMADIN (1 patients)
DICLOFENAC (1 patients)
DICLOFENAC SODIUM (1 patients)
DOXORUBICIN HYDROCHLORIDE (1 patients)
DOXORUBICIN HYROCHLORIDE (1 patients)
ELOXATIN (1 patients)
ENDOXAN (CYCLOPHOSPHAMIDE) (1 patients)
ERLOTINIB HYDROCHLORIDE (1 patients)
ETOPOSIDE (1 patients)
FERROUS SULFATE TAB (1 patients)
FLAGYL (1 patients)
FLAGYL I.V. (1 patients)
FLUDARA I.V. (FLUDARABINE PHOSPAHATE) AMPULE (1 patients)
FLUDARABINE PHOSPHATE (1 patients)
FOLAXIN (1 patients)
FOLIAMIN (1 patients)
FOSAMAX (1 patients)
HYDROCHLOROTHIAZIDE (1 patients)
HYPNOVEL (1 patients)
HYZAAR (1 patients)
IMATINIB MESYLATE (1 patients)
INFLIXIMAB, RECOMBINANT (1 patients)
INSULINE (1 patients)
KIOVIG (1 patients)
LABETALOL HCL (1 patients)
LABH 589 (PANOBINOSTAT) (1 patients)
LBH589 (PANOBINOSTAT) (1 patients)
LEVAQUIN (1 patients)
LEVOTHYROXINE SODIUM (1 patients)
LIPITOR (1 patients)
LISINOPRIL (1 patients)
MABTHERA (RITUXIMAB) (1 patients)
MAGNESIUM OXIDE (1 patients)
MORPHINE (1 patients)
NEORAL (1 patients)
NOVANTRON (MITOXANTRONE, MITOXANTRONE HYDROCHLORDIE) (1 patients)
NOVANTRONE (1 patients)
OXALIPLATIN (1 patients)
OXYNORM (1 patients)
PACLITAXEL (1 patients)
PEG-INTRON (1 patients)
PREDNISOLON (1 patients)
PYRIDOXINE (1 patients)
RAD 666 / RAD 001A (1 patients)
RAD 666 RAD+ (1 patients)
RAPTIVA (1 patients)
REBETOL (1 patients)
REGLAN/USA/(METOCLOPRAMIDE HYDROCHLORIDE) (1 patients)
REOPRO (1 patients)
RITUXIMAB (1 patients)
RIVOTRIL (1 patients)
ROLAIDS (1 patients)
SANDOSTATIN LAR (1 patients)
SKENAN (1 patients)
SOLOSTAR (1 patients)
SYNTHROID (1 patients)
TACROLIMUS, CONTROL FOR SIROLIMUS (TACROLIMUS, CONTROL FOR SIROLIMUS) (1 patients)
TAXOTERE (1 patients)
THALOMID (1 patients)
TOBI (1 patients)
TRACLEER (1 patients)
TRANXENE (1 patients)
TRASYLOL (1 patients)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE (1 patients)
TYKERB (1 patients)
VEPESID (1 patients)
VINCRISTINE SULFATE (1 patients)
WARFARIN (1 patients)
XANAX (1 patients)
XELODA (1 patients)
ZOFRAN (1 patients)

Most common side effects for patients taking PREDNISONE TAB:

DYSPNOEA (2506 patients)
PYREXIA (2069 patients)
PAIN (2055 patients)
NAUSEA (2038 patients)
PNEUMONIA (2030 patients)
FATIGUE (1938 patients)
DIARRHOEA (1769 patients)
ARTHRALGIA (1727 patients)
DRUG INEFFECTIVE (1632 patients)
ASTHENIA (1568 patients)
VOMITING (1534 patients)
HEADACHE (1487 patients)
ANAEMIA (1468 patients)
OEDEMA PERIPHERAL (1336 patients)
PAIN IN EXTREMITY (1188 patients)
WEIGHT DECREASED (1165 patients)
DIZZINESS (1157 patients)
BACK PAIN (1106 patients)
ANXIETY (1095 patients)
ABDOMINAL PAIN (1092 patients)
COUGH (1067 patients)
FALL (1060 patients)
CHEST PAIN (1017 patients)
FEBRILE NEUTROPENIA (957 patients)
SEPSIS (941 patients)
DEHYDRATION (922 patients)
RASH (918 patients)
HYPOTENSION (900 patients)
MALAISE (869 patients)
URINARY TRACT INFECTION (867 patients)
HYPERTENSION (854 patients)
THROMBOCYTOPENIA (847 patients)
RENAL FAILURE (828 patients)
DEATH (816 patients)
DEPRESSION (807 patients)
PULMONARY EMBOLISM (781 patients)
INFECTION (766 patients)
NEUTROPENIA (752 patients)
INJECTION SITE PAIN (749 patients)
RENAL FAILURE ACUTE (740 patients)
RESPIRATORY FAILURE (737 patients)
PLEURAL EFFUSION (692 patients)
HAEMOGLOBIN DECREASED (685 patients)
CONDITION AGGRAVATED (681 patients)
CROHN'S DISEASE (676 patients)
DEEP VEIN THROMBOSIS (665 patients)
PRURITUS (661 patients)
CARDIAC FAILURE CONGESTIVE (654 patients)
INSOMNIA (634 patients)
CONSTIPATION (632 patients)
WEIGHT INCREASED (629 patients)
ATRIAL FIBRILLATION (621 patients)
OSTEONECROSIS (614 patients)
RHEUMATOID ARTHRITIS (605 patients)
ASTHMA (598 patients)
GAIT DISTURBANCE (591 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (589 patients)
HYPOAESTHESIA (583 patients)
BRONCHITIS (581 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (577 patients)
SINUSITIS (575 patients)
CHILLS (562 patients)
CONFUSIONAL STATE (561 patients)
PARAESTHESIA (561 patients)
PANCYTOPENIA (549 patients)
MYALGIA (548 patients)
INJURY (546 patients)
MYOCARDIAL INFARCTION (543 patients)
BLOOD CREATININE INCREASED (534 patients)
ABDOMINAL PAIN UPPER (531 patients)
MUSCULAR WEAKNESS (524 patients)
DECREASED APPETITE (523 patients)
CELLULITIS (519 patients)
ERYTHEMA (516 patients)
CONVULSION (506 patients)
BLOOD GLUCOSE INCREASED (481 patients)
ARTHRITIS (471 patients)
JOINT SWELLING (470 patients)
OSTEOARTHRITIS (451 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (450 patients)
DIABETES MELLITUS (444 patients)
UPPER RESPIRATORY TRACT INFECTION (443 patients)
VISION BLURRED (437 patients)
MUSCLE SPASMS (436 patients)
HERPES ZOSTER (436 patients)
TACHYCARDIA (429 patients)
TREMOR (428 patients)
NEUROPATHY PERIPHERAL (421 patients)
BLOOD PRESSURE INCREASED (419 patients)
OSTEONECROSIS OF JAW (418 patients)
BONE DISORDER (412 patients)
SEPTIC SHOCK (408 patients)
DRUG INTERACTION (406 patients)
LOSS OF CONSCIOUSNESS (403 patients)
PLATELET COUNT DECREASED (402 patients)
CEREBROVASCULAR ACCIDENT (388 patients)
NASOPHARYNGITIS (387 patients)
DYSPHAGIA (384 patients)
STAPHYLOCOCCAL INFECTION (381 patients)
URTICARIA (378 patients)
SYNCOPE (375 patients)
THROMBOSIS (374 patients)
MUSCULOSKELETAL PAIN (374 patients)
MULTI-ORGAN FAILURE (371 patients)
SWELLING (368 patients)
GASTROINTESTINAL HAEMORRHAGE (365 patients)
HYPERHIDROSIS (363 patients)
OSTEOMYELITIS (358 patients)
WHITE BLOOD CELL COUNT DECREASED (352 patients)
CATARACT (352 patients)
ATELECTASIS (351 patients)
CONTUSION (350 patients)
EMOTIONAL DISTRESS (348 patients)
IMPAIRED HEALING (346 patients)
CHEST DISCOMFORT (345 patients)
HEART RATE INCREASED (344 patients)
CARDIAC ARREST (343 patients)
BONE PAIN (341 patients)
DISEASE PROGRESSION (341 patients)
SOMNOLENCE (341 patients)
ALANINE AMINOTRANSFERASE INCREASED (339 patients)
COLITIS ULCERATIVE (336 patients)
PAIN IN JAW (334 patients)
WHEEZING (332 patients)
HYPERGLYCAEMIA (331 patients)
FEELING ABNORMAL (330 patients)
LEUKOPENIA (330 patients)
OSTEOPOROSIS (327 patients)
HYPOKALAEMIA (325 patients)
HYPERSENSITIVITY (321 patients)
HYPOXIA (319 patients)
DRUG EXPOSURE DURING PREGNANCY (319 patients)
OEDEMA (316 patients)
INJECTION SITE ERYTHEMA (315 patients)
ABDOMINAL DISTENSION (314 patients)
DYSPEPSIA (314 patients)
INFUSION RELATED REACTION (313 patients)
LYMPHADENOPATHY (306 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (305 patients)
PALPITATIONS (303 patients)
HAEMORRHAGE (303 patients)
CARDIAC FAILURE (296 patients)
CARDIOMEGALY (296 patients)
COLITIS (296 patients)
PULMONARY OEDEMA (295 patients)
INTERSTITIAL LUNG DISEASE (294 patients)
OSTEOPENIA (292 patients)
WHITE BLOOD CELL COUNT INCREASED (286 patients)
RENAL IMPAIRMENT (285 patients)
KIDNEY TRANSPLANT REJECTION (285 patients)
INFLAMMATION (283 patients)
LUNG DISORDER (282 patients)
ALOPECIA (277 patients)
CYTOMEGALOVIRUS INFECTION (276 patients)
MENTAL STATUS CHANGES (271 patients)
HYPONATRAEMIA (267 patients)
SPINAL OSTEOARTHRITIS (267 patients)
RESPIRATORY DISTRESS (264 patients)
CARDIAC DISORDER (262 patients)
OROPHARYNGEAL PAIN (261 patients)
LUNG INFILTRATION (260 patients)
SWELLING FACE (260 patients)
INTERVERTEBRAL DISC PROTRUSION (254 patients)
MUSCULOSKELETAL STIFFNESS (253 patients)
RECTAL HAEMORRHAGE (252 patients)
CORONARY ARTERY DISEASE (251 patients)
MULTIPLE MYELOMA (250 patients)
ANOREXIA (250 patients)
LIVER FUNCTION TEST ABNORMAL (249 patients)
MUCOSAL INFLAMMATION (249 patients)
PRODUCTIVE COUGH (247 patients)
INFLUENZA LIKE ILLNESS (245 patients)
GASTRITIS (244 patients)
PULMONARY HYPERTENSION (244 patients)
NECK PAIN (242 patients)
INFLUENZA (242 patients)
TOOTH EXTRACTION (240 patients)
CANDIDIASIS (240 patients)
MITRAL VALVE INCOMPETENCE (239 patients)
INJECTION SITE HAEMATOMA (238 patients)
HAEMATURIA (238 patients)
ANHEDONIA (231 patients)
HEPATIC ENZYME INCREASED (230 patients)
ASCITES (228 patients)
CHOLELITHIASIS (227 patients)
LUNG NEOPLASM (226 patients)
MOBILITY DECREASED (225 patients)
AMNESIA (222 patients)
INTERVERTEBRAL DISC DEGENERATION (221 patients)
MEMORY IMPAIRMENT (221 patients)
ABDOMINAL DISCOMFORT (218 patients)
BALANCE DISORDER (218 patients)
HAEMATOCRIT DECREASED (218 patients)
TRANSPLANT REJECTION (218 patients)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (218 patients)
BLOOD PRESSURE DECREASED (217 patients)
PERICARDIAL EFFUSION (216 patients)
LUNG INFECTION (215 patients)
STOMATITIS (214 patients)
NEOPLASM MALIGNANT (213 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (213 patients)
SKIN ULCER (212 patients)
CARDIO-RESPIRATORY ARREST (211 patients)
HAEMATOCHEZIA (211 patients)
PANCREATITIS (211 patients)
DRY MOUTH (210 patients)
LETHARGY (209 patients)
DRUG HYPERSENSITIVITY (208 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (206 patients)
RIB FRACTURE (205 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for PREDNISONE TAB

Issue	Description / Topic	Timestamp
QUESTION PERIORBITAL OEDEMA	Does long use of predinselone tabs causes peri orbital oedema	2015-01-29 13:39:25
QUESTION HYPOPARATHYROIDISM	Had 3 large doses could feel cal go normal then low in 5 second intervals now on lower dose have symtoms of low cal tetany twich lip cramps brain fog itchy ect but blood ok i can feel it change but please explain	2015-04-23 16:45:32
QUESTION DRUG INTERACTION	Interaction between medrol and methamphetamines	2015-07-14 16:44:36
QUESTION DIABETES MELLITUS	I have low t, shortly after starting testosterone therapy applied to the skin(2months or so) I noticed varicose veins in my legs and supposedly had a heart attach. Could there be a correlation between the two? Also shortly after that I became very tired again, but this time I had started juicing while on prednisone, had to be taken to the hospital e.r. and was diagnosed with diabetes type 2. My question is why aren't are our health care providers letting us know potential dangerous side effects and can these two problems be linked with the respective drug therapies?	2016-01-10 14:55:33
QUESTION DRUG INTERACTION	can i take steroids and metoprolol and losartan	2016-01-29 20:57:37
QUESTION BLAST CELL COUNT INCREASED	My husband has been on 60mg of prednisone for minimal change disease since October 2015. A recent CBC showed he has "immature blast cells". Could this be due to the prednisone? I can't find any information on what causes this other than possible leukemia. He was referred to a hemotologist/oncologist but the apt is not until the end of May.	2016-04-25 22:09:42
QUESTION MYALGIA	Is there any problem while taking prednisone tabs	2016-10-17 07:22:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about GASTRIC CANCER STAGE IV and PREDNISONE TAB, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking PREDNISONE TAB, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in PREDNISONE TAB. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for PREDNISONE TAB experts. If you are a healthcare provider experienced in prescribing PREDNISONE TAB, please register here.